Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Mencia De Lemus"'
Autor:
Tina Duong, Jessica Braid, Hannah Staunton, Aurelie Barriere, Fani Petridis, Johannes Reithinger, Rosangel Cruz, Jill Jarecki, Mencia De Lemus, Nicole Gusset, Ria Broekgaarden, Sharan Randhawa, Jessica Flynn, Rob Arbuckle, Sonia Reif, Lida Yang, Angela De Martini, Carole Vuillerot
Publikováno v:
BMC Neurology, Vol 21, Iss 1, Pp 1-4 (2021)
Externí odkaz:
https://doaj.org/article/3e7969a63e0b479d964476d929ecea58
Autor:
Tina Duong, Jessica Braid, Hannah Staunton, Aurelie Barriere, Fani Petridis, Johannes Reithinger, Rosangel Cruz, Jill Jarecki, Mencia De Lemus, Nicole Gusset, Ria Broekgaarden, Sharan Randhawa, Jessica Flynn, Rob Arbuckle, Sonia Reif, Lida Yang, Angela De Martini, Carole Vuillerot
Publikováno v:
BMC Neurology, Vol 21, Iss 1, Pp 1-14 (2021)
Abstract Background The 32-item Motor Function Measure (MFM32) is a clinician-reported outcome measure used to assess the functional abilities of individuals with neuromuscular diseases, including those with spinal muscular atrophy (SMA). This two-pa
Externí odkaz:
https://doaj.org/article/40a4d4e72db647e4b617a358a6c10774
Autor:
Nora Tula Detering, Alberto Zambon, Niko Hensel, Rashmi Kothary, Kathryn Swoboda, Thomas H. Gillingwater, Giovanni Baranello, Simon Parson, Mariascristina Scoto, Melissa Bowerman, John Vissing, Brunhilde Wirth, Peter Claus, Janbernd Kirschner, Enrico Bertini, Stefania Corti, Lorenzo Maggi, Ludo van der Pol, Ewout Groen, Charlotte Sumner, Eduardo Tizzano, Susana Quijano Roy, Isabelle Desguerre, Alexander Van Nuijs, Mencia De Lemus, Rivka Smit, Mary Schroth, Ben Tichler, Ksenija Gorni, Deepa Chand
Publikováno v:
Neuromuscular Disorders. 32:697-705
Autor:
Mencía de Lemus, Maria G. Cattinari, Samuel I. Pascual, Julita Medina, Mar García, Ana Magallón, María Dumont, Pablo Rebollo
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 8, Iss 1, Pp 1-11 (2024)
Abstract Background SMA is a hereditary neuromuscular disease that causes progressive muscle weakness and atrophy. Several studies have shown that the burden of SMA is very high at many levels. Functional assessment tools currently used do not comple
Externí odkaz:
https://doaj.org/article/3a56ccfe2f9049c1ad75a85da6dcad2c
Publikováno v:
European Journal of Paediatric Neurology, 30, 105-107. W.B. Saunders Ltd
Response to letter: A decision for life – Treatment decisions in newly diagnosed families with spinal muscular atrophy, European Journal of Paediatric Neurology, Volume 30, January 2021, Pages 103-104
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 19, Iss 1, Pp 1-13 (2024)
Abstract Background Spinal Muscular Atrophy (SMA) is a rare neuromuscular disorder characterized by progressive degeneration of motor neurons and muscle weakness resulting in premature death or severe motor disability. Over the last decade, SMA has d
Externí odkaz:
https://doaj.org/article/d134da28f89d4e76a436de919ede578a
Autor:
Mike Snape, Aad Tibben, Baziel G.M. van Engelen, Mencia de Lemus, Hanns Lochmüller, Alexandra Breukel, Holly L. Peay, Nathalie Bere, Ellen Sterrenburg, George W. Padberg, Raffaella Willmann, Erik Landfeldt, Ingeborg Meijer, Lucia Monaco, Anna Ambrosini, Guus Schrijvers, Elena S. Mazzone, Mats G. Hansson, Anne Lennox
Publikováno v:
Journal of Neuromuscular Diseases, 6, 1, pp. 161-172
Journal of Neuromuscular Diseases, 6(1), 161-172
Journal of Neuromuscular Diseases, 6, 161-172
Journal of Neuromuscular Diseases, 6(1), 161-172
Journal of Neuromuscular Diseases, 6, 161-172
Contains fulltext : 207092.pdf (Publisher’s version ) (Closed access) In the era of patient-centered medicine, shared decision-making (SDM) - in which healthcare professionals and patients exchange information and preferences and jointly reach a de
Autor:
Fani Petridis, Lida Yang, Jessica Flynn, Jill Jarecki, Angela De Martini, Johannes Reithinger, Rob Arbuckle, Ria Broekgaarden, Sonia Reif, Hannah Staunton, Tina Duong, Aurelie Barriere, Carole Vuillerot, Nicole Gusset, Jessica Braid, Sharan Randhawa, Mencia de Lemus, Rosangel Cruz
Publikováno v:
BMC Neurology
BMC Neurology, BioMed Central, 2021, 21 (1), pp.143. ⟨10.1186/s12883-021-02166-z⟩
BMC Neurology, 2021, 21 (1), pp.143. ⟨10.1186/s12883-021-02166-z⟩
BMC Neurology, Vol 21, Iss 1, Pp 1-14 (2021)
BMC Neurology, BioMed Central, 2021, 21 (1), pp.143. ⟨10.1186/s12883-021-02166-z⟩
BMC Neurology, 2021, 21 (1), pp.143. ⟨10.1186/s12883-021-02166-z⟩
BMC Neurology, Vol 21, Iss 1, Pp 1-14 (2021)
Background The 32-item Motor Function Measure (MFM32) is a clinician-reported outcome measure used to assess the functional abilities of individuals with neuromuscular diseases, including those with spinal muscular atrophy (SMA). This two-part study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::527932df41f923d6b9d4fa7442fdada2
https://www.hal.inserm.fr/inserm-03310641
https://www.hal.inserm.fr/inserm-03310641
Autor:
Nicole Gusset, Caroline Stalens, Mencia de Lemus, Marie-Christine Ouillade, Eva Stumpe, Alexandre Mejat, Lori Klouvi
Publikováno v:
Neuromuscular disorders : NMD. 31(5)
Following the 2017 approval of a first spinal muscular atrophy (SMA) treatment by the European Medicines Agency, SMA Europe launched a Europe-wide survey with the goal of understanding patients' treatment expectations, realities of daily living and a
Autor:
Eugenio Mercuri, Sonia Messina, Jacqueline Montes, Francesco Muntoni, Valeria A. Sansone, Laura Antonaci, Matt Civitello, Giorgia Coratti, Mencia de Lemus, Roberto de Sanctis, Marcus Droege Avexis, Tina Duong, Richard Finkel, Anna Lia Frongia, Ksenija Gorni Roche, Chad Heatwole, Nicole Gusset, Erik Henricson, Anna Mayhew, Chiara Marchesi, Amy Pasternak, Astrid Pechmann, Maria Carmela Pera, Ivana Rubino, Valeria Sansone, Mary Schroth, Dylan Trundell, Volker Straub
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a631e903c9e3ed2f54be943d6ad2b113
http://hdl.handle.net/10807/182745
http://hdl.handle.net/10807/182745